140 related articles for article (PubMed ID: 22965877)
21. Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization.
Hongo H; Kihara T; Kume T; Izumi Y; Niidome T; Sugimoto H; Akaike A
Biochem Biophys Res Commun; 2012 Sep; 426(1):94-9. PubMed ID: 22922102
[TBL] [Abstract][Full Text] [Related]
22. Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo.
Bitner RS; Nikkel AL; Markosyan S; Otte S; Puttfarcken P; Gopalakrishnan M
Brain Res; 2009 Apr; 1265():65-74. PubMed ID: 19230830
[TBL] [Abstract][Full Text] [Related]
23. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
Li T; Paudel HK
Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.
Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ
J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798
[TBL] [Abstract][Full Text] [Related]
25. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.
Vossel KA; Xu JC; Fomenko V; Miyamoto T; Suberbielle E; Knox JA; Ho K; Kim DH; Yu GQ; Mucke L
J Cell Biol; 2015 May; 209(3):419-33. PubMed ID: 25963821
[TBL] [Abstract][Full Text] [Related]
26. 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain.
Yuan Z; Agarwal-Mawal A; Paudel HK
J Biol Chem; 2004 Jun; 279(25):26105-14. PubMed ID: 15073173
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.
Sun W; Qureshi HY; Cafferty PW; Sobue K; Agarwal-Mawal A; Neufield KD; Paudel HK
J Biol Chem; 2002 Apr; 277(14):11933-40. PubMed ID: 11812770
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility to GSK3β-induced tau phosphorylation differs between the young and aged hippocampus after Wnt signaling inhibition.
Salcedo-Tello P; Hernández-Ortega K; Arias C
J Alzheimers Dis; 2014; 39(4):775-85. PubMed ID: 24270208
[TBL] [Abstract][Full Text] [Related]
29. Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway.
Chen KL; Yuan RY; Hu CJ; Hsu CY
Neurobiol Dis; 2010 Nov; 40(2):378-85. PubMed ID: 20615469
[TBL] [Abstract][Full Text] [Related]
30. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
Leroy A; Landrieu I; Huvent I; Legrand D; Codeville B; Wieruszeski JM; Lippens G
J Biol Chem; 2010 Oct; 285(43):33435-33444. PubMed ID: 20679343
[TBL] [Abstract][Full Text] [Related]
31. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
32. Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.
Sen T; Saha P; Jiang T; Sen N
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4418-4427. PubMed ID: 32051249
[TBL] [Abstract][Full Text] [Related]
33. C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells.
Guo H; Wang H; Wang C; Cheng Y; Zou Z; Li Y; Wu J; Xu J
J Mol Neurosci; 2015 Jun; 56(2):519-27. PubMed ID: 25966642
[TBL] [Abstract][Full Text] [Related]
34. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
35. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
[TBL] [Abstract][Full Text] [Related]
36. Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.
Tortosa E; Santa-Maria I; Moreno F; Lim F; Perez M; Avila J
J Alzheimers Dis; 2009; 17(2):319-25. PubMed ID: 19363271
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Glycogen Synthase Kinase-3β by Phosphorylation and O-β-Linked N-Acetylglucosaminylation: Implications on Tau Protein Phosphorylation.
El Hajjar L; Page A; Bridot C; Cantrelle FX; Landrieu I; Smet-Nocca C
Biochemistry; 2024 Jun; 63(12):1513-1533. PubMed ID: 38788673
[TBL] [Abstract][Full Text] [Related]
38. Interaction of Tau with Fe65 links tau to APP.
Barbato C; Canu N; Zambrano N; Serafino A; Minopoli G; Ciotti MT; Amadoro G; Russo T; Calissano P
Neurobiol Dis; 2005 Mar; 18(2):399-408. PubMed ID: 15686969
[TBL] [Abstract][Full Text] [Related]
39. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β.
Kawakami F; Suzuki M; Shimada N; Kagiya G; Ohta E; Tamura K; Maruyama H; Ichikawa T
FEBS J; 2011 Dec; 278(24):4895-904. PubMed ID: 21985244
[TBL] [Abstract][Full Text] [Related]
40. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
